Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
WST.US
id: 1587

West ($WST) Misleading Demand Visibility and Revenue Drop Case

Investors can submit applications for the lead plaintiff role.
E.D. Pennsylvania
Court
2:25-cv-02285
Case number
02/16/2023
Class period Start
02/12/2025
Class period End
07/04/2025
Lead Plaintiff motion deadline
  • $WST investors filed a claim against West Pharmaceutical for hiding customer losses and downplaying financial risks tied to high-value products.
  • After lowering its 2025 guidance and revealing the loss of two major customers, $WST dropped by 38% on February 13, 2025.
  • $WST investors can join this case to be notified about potential recovery.
Case Details:

Between February 17, 2023 and February 16, 2025, West Pharmaceutical told investors that demand for its products was normalizing after pandemic highs, but insisted that the business remained strong. Executives emphasized customer stability, high visibility into demand, and long-term growth in its contract manufacturing and SmartDose product lines.

What the company didn’t disclose was that two of its largest customers in the continuous glucose monitoring (CGM) market had already decided to take production in-house—quietly ending contracts that made up more than 20% of West’s manufacturing revenue. At the same time, costs were rising and the company's SmartDose injector had become less profitable than the company had previously suggested.

On February 13, 2025, West cut its 2025 guidance, admitted the customer losses, and revealed that SmartDose would hurt margins going forward.

Following this, $WST dropped 38%.

Based on these events, $WST investors filed a claim against West Pharmaceutical, accusing the company of the following:
  • It misled investors about demand visibility and the strength of key product lines.
  • It failed to disclose the financial impact of losing major clients and weakening margins on flagship products.
Investors believe West downplayed serious risks while promoting a narrative of stable growth and profitability.
Case Status
Lead Plaintiff Submission
Alleged Offence
Misleading Statements
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
03/13/2025
Filing date
05/05/2025
Lead Plaintiff Deadline
07/04/2025

West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, a...

    Ticker
    WST.US
    ISIN
    US9553061055
    CIK
    0000105770
    Sector
    Healthcare
    Industry
    Medical Instruments & Supplies
    Country
    USA
    Address
    530 Herman O. West Drive, Exton, PA, United States, 19341-1147